Search clinical trials for: Fibrin Sealant

Total 6505 results

Rovi Pharmaceuticals Laboratories

Completed

CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)

Cancer | Venous Thromboembolism

Spain, Portugal, Romania, Russian Federation
National Institute of Cancerología
Kimberly-Clark de México

Unknown

Comparison of Iodine + Isopropyl Alcohol Versus Iodine + Antimicrobial Sealant for Skin Preparation

Surgical Site Infection

Mexico
Otsuka Beijing Research Institute

Completed

Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker

Type 2 Diabetes Mellitus | Arteriosclerosis Obliterans

China
Kosuyolu Heart Hospital
The Society of Cardiac Health Protection

Completed

Tirofiban Intracoronary Bolus-only Versus Intravenous Bolus Plus Infusion in STEMI Patients

Acute Myocardial Infarction
Johann Wolfgang Goethe University Hospital

Unknown

Generation of Heparin-induced Thrombocytopenia (HIT)-Antibodies Without Prior Heparin Exposure

Thrombosis | Heparin-Induced Thrombocytopenia

Germany
Uppsala University

Completed

Tailoring Of Platelet Inhibition to Avoid Stent Thrombosis (TOPAS-1)

Myocardial Infarction | Heart Diseases | Coronary Artery Disease | Acute Coronary Syndrome | Stent Thrombosis

Sweden
Johann Wolfgang Goethe University Hospital

Unknown

Determination of Residual Anticoagulatory Effects of Fondaparinux

Anticoagulant Prophylaxis/Therapy

Germany
Medical University of Lodz

Unknown

Vitamin K2 and Vessel Calcification in Chronic Kidney Disease Patients (CACSK2)

Kidney Diseases | Coronary Artery Calcification

Poland
University of Rochester

Completed

Platelet Function And Aggregometry In Patients With Aortic Valve Stenosis

Hemorrhage

United States
Sanofi

Completed

Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery

Abdominal Neoplasms

Japan
The Prince Charles Hospital
Sanofi; Merck Sharp & Dohme LLC

Completed

Tirofiban and Enoxaparin in High Risk Coronary Intervention

Acute Coronary Syndrome

Australia
CardioVascular Research Foundation, Korea
Otsuka Korea

Completed

Triple Versus Dual Antiplatelet Therapy After ABT578-Eluting Stent (DECLARELONG)

Coronary Artery Disease

Korea, Republic of
Fundacio d'Investigacio en Atencio Primaria Jordi...
SCMFIC FAMILY DOCTORS CATALAN SOCIETY GRANT

Completed

Clinical Intervention Study in the Primary Care Setting of Patients With High Plasma Fibrinogen (EFAP) (EFAP)

Cardiovascular Risk Factors

Spain
Johann Wolfgang Goethe University Hospital

Suspended

ASA- and Clopidogrel-Responsiveness in Patients With Peripheral Arterial Occlusive Disease and Interventional Procedures

Peripheral Arterial Occlusive Disease

Germany
Deutsches Herzzentrum Muenchen
Technical University of Munich

Completed

Value of Abciximab in Patients With AMI Undergoing Primary PCI After Clopidogrel Pretreatment (BRAVE 3)

Myocardial Infarction

Germany, Austria
Deutsches Herzzentrum Muenchen

Completed

Un-fractionated Heparin Versus Bivalirudin During Percutaneous Coronary Interventions (PCI) (ISAR-REACT-3)

Coronary Disease | Angina Pectoris

Germany
HeartDrug Research LLC
University of Oslo

Unknown

Effects of Omega-3 Fatty Acids on Platelets in Patients With Coronary Artery Disease With Hypertriglyceridemia (OMPA-CAD)

Coronary Artery Disease

United States
CoAxia

Completed

Feasibility and Safety of NeuroFlo in Stroke Patients Receiving Tissue Plasminogen Activator (FASTFlo tPA)

Ischemic Stroke

Canada, Germany
Eastern Virginia Medical School
Abbott

Completed

Role of Prostaglandins on Niacin-Induced Flushing

Flushing

United States
McMaster University
The Physicians' Services Incorporated Foundation; Canadian Network and Centre...

Completed

PeriOperative ISchemic Evaluation-2 Pilot (POISE2-pilot)

Cardiovascular Disease

China, Canada
Bristol-Myers Squibb

Completed

BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery

Venous Thrombosis | Pulmonary Embolism

United States, Argentina, Canada, Mexico, Puerto Rico, Israel, Australia, Poland, Denmark
Bristol-Myers Squibb

Completed

Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT Study

Deep-Vein Thrombosis

Netherlands, Austria, Italy, South Africa, Israel, United States, France, Australia, Poland, Sweden, Czech Republic
Ranbaxy Laboratories Limited

Completed

A Relative Bioavailability Study of Acetaminophen 650 mg Extended Release Gelcaps Under Fed Condition

Healthy

India
Otsuka Pharmaceutical, Inc., Philippines

Completed

Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the Philippines (ASCEND)

Polyneuropathy

Philippines
Ranbaxy Laboratories Limited

Completed

A Relative Bioavailability Study of Acetaminophen 650 mg Extended Release Gelcaps Under Fasting Condition

Healthy

India
Centre Hospitalier Universitaire de Saint Etienne

Completed

Pharmacokinetics of Fondaparinux in Patients With Major Orthopedic Surgery (POP-A-RIX)

Orthopedic Surgery

France
Hallym University Medical Center

Unknown

Re-STOP DVT: Reload of High Dose Atorvastatin for Preventing Deep Vein Thrombosis in Statin Users (Re-STOP DVT)

Thrombosis | Surgery | Prevention

Korea, Republic of
Fundació Institut de Recerca de l'Hospital de la...

Terminated

Bemiparin Randomized Trial on Bridging Oral Anticoagulants in Invasive Procedures (BERTA Study) (BERTA)

Long-term Oral Anticoagulant Therapy

Spain
ARCA Biopharma, Inc.

Completed

Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access Devices

Catheters, Indwelling

United States
Ontario Clinical Oncology Group (OCOG)
Pfizer

Completed

Fragmin in Ovarian Cancer: Utility on Survival (FOCUS)

Ovarian Cancer

Canada
Sanofi

Completed

Enoxaparin in Acute Venous Thromboembolic Disease

Venous Thrombosis

Turkey
Assaf-Harofeh Medical Center

Completed

Pharmacological Study That Measures Omeprazole Effect on Aspirins Absorption in Healthy Volunteers

Aspirin Blood Level | Proton Pump Inhiditor Treatment

Israel
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Precancerous/Nonmalignant Condition

United States
Luzerner Kantonsspital
Pfizer

Completed

Pharmacokinetics of Dalteparin in Patients With Impaired Renal Function

Renal Insufficiency

Switzerland
Asan Medical Center
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Overcome Biochemical Aspirin Resistance Through Cilostazol Combination (ARCC)

Cerebral Infarction

Korea, Republic of
Temple University

Completed

The Effect of Implementing Hyper-acute Stroke Guidelines on Decision-Making for or Against Thrombolytic Therapy for Stroke in the Emergency Department

Stroke

United States
Asan Medical Center
Korea Otsuka International Asia Arab

Completed

Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II (TOSS-2)

Atherosclerosis | Cerebral Infarction

Philippines, Korea, Republic of, Thailand, Hong Kong
Neurobiological Technologies

Terminated

ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke

Stroke | Brain Infarction | Cerebral Ischemia

United States, Australia, Israel, South Africa, Slovakia, New Zealand, Austria, Czech Republic, Poland, Russian Federation, Switzerland
University of North Carolina, Chapel Hill

Completed

Daily Vitamin K in Patients on Warfarin With Unstable INRs

Anticoagulants | Warfarin

United States
National Taiwan University Hospital

Unknown

Investigation of Platelet Function and Aspirin Resistance in Chronic Dialysis Patient

End Stage Renal Disease

Taiwan
Neurobiological Technologies

Terminated

Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke

Stroke | Brain Infarction | Cerebral Ischemia

Taiwan, United States, Australia, South Africa, Canada, Czech Republic, Netherlands, Poland, Russian Federation, United Kingdom
Mutual Pharmaceutical Company, Inc.

Completed

Fasted Bioavailability Study of Cilostazol Tablets, 50mg

Therapeutic Equivalency, Healthy
Mutual Pharmaceutical Company, Inc.

Completed

Fasted Bioavailability Study of Cilostazol Tablets, 100 mg

Therapeutic Equivalency
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of Cilostazol for the Indication of CSPS

Cerebral Infarction

Korea, Republic of
University of North Carolina, Chapel Hill

Completed

Mechanisms Underlying Drug-Diet Interactions

Pharmacokinetics

United States
Korea Otsuka Pharmaceutical Co., Ltd.
Seoul National University Boramae Hospital; Korea Otsuka International Asia...

Completed

Cilostazol in Acute Ischemic Stroke Treatment (CAIST)

Cerebral Infarction

Korea, Republic of
Bayer

Completed

Symptomatic Treatment of Common Cold Symptoms

Common Cold

Italy
University Hospital, Saarland
Baxter Healthcare Corporation; Pharmacia GmbH, Erlangen, Germany

Completed

Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) (TAHHT)

Hereditary Hemorrhagic Telangiectasia

Germany
Bayer

Completed

Placebo and Active Controlled, Double Dummy Study to Prove Efficacy of Aspirin in Treatment of Acute Low Back Pain

Low Back Pain

United Kingdom, Germany
Yodakubo Hospital

Completed

Effect of Tranexamic Acid on Reducing Postoperative Blood Loss in Cervical Laminoplasty

Cervical Myelopathy

Search clinical trials for: Fibrin Sealant

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations